Search Results - "FILVAROFF, Ellen"
-
1
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms
Published in PloS one (17-09-2019)“…Second-generation mammalian target of rapamycin (mTOR) inhibitors such as CC-223 may have theoretical advantages over first-generation drugs by inhibiting TOR…”
Get full text
Journal Article -
2
Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies
Published in Cancer (01-09-2022)“…Background CC‐90011 is an oral, potent, selective, reversible inhibitor of lysine‐specific demethylase 1 (LSD1) that was well tolerated, with encouraging…”
Get full text
Journal Article -
3
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma
Published in Clinical cancer research (15-01-2021)“…Lysine-specific demethylase 1 (LSD1) is implicated in multiple tumor types, and its expression in cancer stem cells is associated with chemoresistance…”
Get full text
Journal Article -
4
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance
Published in Molecular cancer research (01-02-2019)“…As a critical signaling node, ERK1/2 are attractive drug targets, particularly in tumors driven by activation of the MAPK pathway. Utility of targeting the…”
Get full text
Journal Article -
5
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia
Published in Blood (28-07-2016)“…Inhibition of B-cell receptor (BCR) signaling pathways in chronic lymphocytic leukemia (CLL) provides significant clinical benefit to patients, mainly by…”
Get full text
Journal Article -
6
Shallow shotgun sequencing reduces technical variation in microbiome analysis
Published in Scientific reports (11-05-2023)“…The microbiome is known to play a role in many human diseases, but identifying key microbes and their functions generally requires large studies due to the…”
Get full text
Journal Article -
7
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy
Published in Cancer management and research (01-12-2019)“…This first-in-human Phase I study investigated the safety, pharmacokinetics (PK), pharmacodynamic profile, and preliminary efficacy of CC-115, a dual inhibitor…”
Get full text
Journal Article -
8
Author Correction: Shallow shotgun sequencing reduces technical variation in microbiome analysis
Published in Scientific reports (13-03-2024)Get full text
Journal Article -
9
Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis
Published in Cancer cell (01-04-2008)“…Metastasis, which commonly uses lymphatics, accounts for much of the mortality associated with cancer. The vascular endothelial growth factor (VEGF)-C…”
Get full text
Journal Article -
10
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Published in Nature communications (13-03-2023)“…Bromodomain and extraterminal proteins (BET) play key roles in regulation of gene expression, and may play a role in cancer-cell proliferation, survival, and…”
Get full text
Journal Article -
11
Angiogenesis and bone repair
Published in Drug Discovery Today (01-11-2003)“…The intimate connection, both physical and biochemical, between blood vessels and bone cells has long been recognized. Genetic, biochemical, and…”
Get full text
Book Review Journal Article -
12
Vascular Endothelial Growth Factor Stimulates Bone Repair by Promoting Angiogenesis and Bone Turnover
Published in Proceedings of the National Academy of Sciences - PNAS (23-07-2002)“…Several growth factors are expressed in distinct temporal and spatial patterns during fracture repair. Of these, vascular endothelial growth factor, VEGF, is…”
Get full text
Journal Article -
13
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies
Published in Clinical cancer research (15-09-2019)“…DNA-dependent protein kinase catalytic subunit (DNA-PK) is a pleiotropic kinase involved in DNA repair and transcriptional regulation. DNA-PK is deregulated in…”
Get full text
Journal Article -
14
Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1
Published in Science translational medicine (14-12-2011)“…Clinical use of recombinant fibroblast growth factor 21 (FGF21) for the treatment of type 2 diabetes and other disorders linked to obesity has been proposed;…”
Get more information
Journal Article -
15
SMG1, a nonsense‐mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma
Published in Molecular oncology (01-02-2023)“…Early data suggested that CC‐115, a clinical molecule, already known to inhibit the mammalian target of rapamycin kinase (TORK) and DNA‐dependent protein…”
Get full text
Journal Article -
16
DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway
Published in Clinical cancer research (15-09-2019)“…Protein kinases are known to play a prominent role in oncogenic progression across multiple cancer subtypes, yet their role in prostate cancer progression…”
Get full text
Journal Article -
17
TGF-β Regulates the Mechanical Properties and Composition of Bone Matrix
Published in Proceedings of the National Academy of Sciences - PNAS (27-12-2005)“…The characteristic toughness and strength of bone result from the nature of bone matrix, the mineralized extracellular matrix produced by osteoblasts. The…”
Get full text
Journal Article -
18
Angiogenesis Is Required for Successful Bone Induction During Distraction Osteogenesis
Published in Journal of bone and mineral research (01-07-2005)“…The role of angiogenesis during mechanically induced bone formation is incompletely understood. The relationship between the mechanical environment,…”
Get full text
Journal Article -
19
TWEAK Attenuates the Transition from Innate to Adaptive Immunity
Published in Cell (02-12-2005)“…Innate immunity is the first line of defense against infection, protecting the host during the development of adaptive immunity and critically affecting the…”
Get full text
Journal Article -
20
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding
Published in The EMBO journal (01-10-2001)“…The proinflammatory cytokine interleukin 17 (IL‐17) is the founding member of a family of secreted proteins that elicit potent cellular responses. We report a…”
Get full text
Journal Article